We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
-1.16%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$21.5B
AUM Growth
-$2.05B
Cap. Flow
+$21.4B
Cap. Flow %
99.3%
Top 10 Hldgs %
12.62%
Holding
2,011
New
1,880
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$587M
2
AAPL icon
Apple
AAPL
+$541M
3
TSM icon
TSMC
TSM
+$392M
4
CSX icon
CSX Corp
CSX
+$262M
5
AMZN icon
Amazon
AMZN
+$237M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 21.91%
2 Healthcare 13.72%
3 Consumer Discretionary 12.54%
4 Financials 11.02%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAVM icon
1851
PAVmed
PAVM
$34.9M
$12K ﹤0.01%
+30
New +$17K
CDAK
1852
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$12K ﹤0.01%
+15,198
New +$31.9K
KOPN icon
1853
Kopin
KOPN
$676M
$11K ﹤0.01%
+10,870
New +$15.2K
LVO icon
1854
LiveOne
LVO
$68.9M
$11K ﹤0.01%
+1,550
New +$16.4K
OTRK
1855
DELISTED
Ontrak
OTRK
$11K ﹤0.01%
+270
New +$18.9K
NEXI
1856
DELISTED
NexImmune, Inc. Common Stock
NEXI
$11K ﹤0.01%
+813
New +$23.8K
ONCT
1857
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$11K ﹤0.01%
+645
New +$13.8K
AMPE
1858
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$11K ﹤0.01%
+623
New +$21.8K
APLT
1859
DELISTED
Applied Therapeutics
APLT
$10K ﹤0.01%
+11,287
New +$13.5K
COCHW icon
1860
Envoy Medical Warrant
COCHW
$443K
$10K ﹤0.01%
+279,455
New +$25.3K
ERNA icon
1861
Eterna Therapeutics
ERNA
$4.71M
$10K ﹤0.01%
+6
New +$20.7K
CBIO
1862
Crescent Biopharma
CBIO
$620M
$10K ﹤0.01%
+176
New +$12.6K
KALA icon
1863
KALA BIO
KALA
$12M
$10K ﹤0.01%
+18
New +$14.1K
RGS icon
1864
Regis Corp
RGS
$68.8M
$10K ﹤0.01%
+504
New +$11.1K
XLI icon
1865
State Street Industrial Select Sector SPDR ETF
XLI
$34B
$10K ﹤0.01%
+122
New +$11.2K
TRVN
1866
DELISTED
Trevena, Inc.
TRVN
$10K ﹤0.01%
+101
New +$15.5K
IVC
1867
DELISTED
Invacare Corporation
IVC
$10K ﹤0.01%
+12,387
New +$13K
UAVS icon
1868
AgEagle Aerial Systems
UAVS
$40.3M
$9K ﹤0.01%
+19
New +$11.8K
UWMC.WS
1869
DELISTED
UWM Holdings Warrants
UWMC.WS
$9K ﹤0.01%
+66,055
New +$12.1K
TLIS
1870
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$9K ﹤0.01%
+873
New +$11K
AWH
1871
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$9K ﹤0.01%
+1,567
New +$16.9K
LABP
1872
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$9K ﹤0.01%
+1,439
New +$12.5K
DRRX
1873
DELISTED
DURECT Corp
DRRX
$8K ﹤0.01%
+1,470
New +$8.96K
LITS
1874
Lite Strategy Inc
LITS
$34M
$8K ﹤0.01%
+1,094
New +$11.3K
NCMI icon
1875
National CineMedia
NCMI
$363M
$8K ﹤0.01%
+1,269
New +$15.3K

Similar funds

Man Group's Q3 2022 Portfolio in Review

As of Q3 2022, Man Group held 2,011 positions worth $21.5B, down 8.7% from $23.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Man Group deployed $21.4B of net new capital in Q3 2022, opening 1,880 new positions. Its largest new stake was Microsoft: 2,221,283 shares worth $517M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Man Group's largest Q3 2022 buy was Microsoft: 2,221,283 shares worth $517M.
  • Man Group's ten largest holdings make up 13% of its $21.5B portfolio in Q3 2022.
  • Man Group opened 1,880 new positions and closed 0 in Q3 2022.
  • Man Group's portfolio value fell 8.7% quarter-over-quarter to $21.5B.

Based on Man Group's 13F filing for Q3 2022, filed 14 Nov 2022.